Emmanuel Archavlis

470 total citations
19 papers, 340 citations indexed

About

Emmanuel Archavlis is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Emmanuel Archavlis has authored 19 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 9 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Emmanuel Archavlis's work include Inflammatory Bowel Disease (11 papers), Microscopic Colitis (7 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Emmanuel Archavlis is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Microscopic Colitis (7 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Emmanuel Archavlis collaborates with scholars based in Greece, Australia and Spain. Emmanuel Archavlis's co-authors include Gerassimos J. Mantzaris, Kalliopi Petraki, Konstantinos Papamichael, Angeliki Christidou, Michael Sfakianakis, Séverine Vermeire, Marc Ferrante, Geert D’Haens, Martin Bortlík and Gert Van Assche and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Nutrients.

In The Last Decade

Emmanuel Archavlis

18 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel Archavlis Greece 7 246 218 173 53 45 19 340
Gavin Barr Australia 9 206 0.8× 177 0.8× 155 0.9× 60 1.1× 33 0.7× 15 315
Ritva Koskela Finland 9 326 1.3× 344 1.6× 152 0.9× 63 1.2× 13 0.3× 17 423
WJ Sandborn United States 10 234 1.0× 212 1.0× 107 0.6× 29 0.5× 22 0.5× 21 360
Timo Blomster Finland 6 232 0.9× 216 1.0× 125 0.7× 23 0.4× 13 0.3× 11 280
Elaine Queener United States 12 380 1.5× 349 1.6× 262 1.5× 170 3.2× 13 0.3× 18 530
Tommy Holmström Sweden 8 266 1.1× 257 1.2× 128 0.7× 34 0.6× 18 0.4× 11 331
J Bélaïche Belgium 8 296 1.2× 263 1.2× 136 0.8× 42 0.8× 31 0.7× 20 361
Cristóbal de la Coba Ortiz Spain 7 88 0.4× 81 0.4× 227 1.3× 115 2.2× 8 0.2× 17 302
Nick Cariglia Iceland 10 203 0.8× 248 1.1× 111 0.6× 61 1.2× 17 0.4× 17 385
S. Quaranta Italy 4 116 0.5× 115 0.5× 365 2.1× 87 1.6× 20 0.4× 7 465

Countries citing papers authored by Emmanuel Archavlis

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Archavlis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Archavlis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Archavlis more than expected).

Fields of papers citing papers by Emmanuel Archavlis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Archavlis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Archavlis. The network helps show where Emmanuel Archavlis may publish in the future.

Co-authorship network of co-authors of Emmanuel Archavlis

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Archavlis. A scholar is included among the top collaborators of Emmanuel Archavlis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Archavlis. Emmanuel Archavlis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Yannakoulia, Mary, Gerassimos J. Mantzaris, Emmanuel Archavlis, et al.. (2022). Assessment of Dietary Adequacy and Quality in a Sample of Patients with Crohn’s Disease. Nutrients. 14(24). 5254–5254. 6 indexed citations
3.
Ferrante, Marc, Konstantinos Papamichael, Dana Ďuricová, et al.. (2015). Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn’s Disease Recurrence. Journal of Crohn s and Colitis. 9(8). 617–624. 32 indexed citations
4.
Papamichael, Konstantinos, et al.. (2015). Simethicone adjunct to polyethylene glycol improves small bowel capsule endoscopy imaging in non-Crohn's disease patients.. PubMed. 28(4). 464–8. 10 indexed citations
6.
Ferrante, Marc, Konstantinos Papamichael, Dana Ďuricová, et al.. (2014). Mo1230 Systematic Versus Endoscopy-Driven Treatment With Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence: Interim Results From a Randomized, Multicenter Trial. Gastroenterology. 146(5). S–592. 2 indexed citations
7.
Papamichael, Konstantinos, Maria Gazouli, Emmanuel Archavlis, et al.. (2014). Su1393 Primary Non Response to Infliximab in Patients With Inflammatory Bowel Disease. Gastroenterology. 146(5). S–457. 2 indexed citations
9.
Papamichael, Konstantinos, et al.. (2012). Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: A prospective, two-year, single center, pilot study. Journal of Crohn s and Colitis. 6(9). 924–931. 75 indexed citations
10.
Papamichael, Konstantinos, et al.. (2012). Granular cell tumour in a patient with Crohn’s disease treated with infliximab. European Journal of Gastroenterology & Hepatology. 24(7). 857–859. 2 indexed citations
11.
Mantzaris, Gerassimos J., et al.. (2011). Pilot Study of Adalimumab for Early Prevention and/or Treatment of Post-Operative Endoscopic Recurrence of Crohn's Disease. Gastroenterology. 140(5). S–275. 3 indexed citations
12.
Papamichael, Konstantinos, Emmanuel Archavlis, Ioannis Theodoropoulos, et al.. (2010). S2044 Effect of a Gluten Free Diet on Bone Mineral Density in Patients With Celiac Disease. Gastroenterology. 138(5). S–308. 1 indexed citations
13.
Theodoropoulos, Ioannis, et al.. (2009). M1069 A Lyophilized Form of S. Boulardii Enhances the Effect of Omeprazole-Triple Therapy in Patients with Organic or Functional Dyspepsia. Gastroenterology. 136(5). A–343. 1 indexed citations
14.
Mantzaris, Gerassimos J., et al.. (2004). A Prospective Randomized Observer-Blind 2-Year Trial of Azathioprine Monotherapy versus Azathioprine and Olsalazine for the Maintenance of Remission of Steroid-Dependent Ulcerative Colitis. The American Journal of Gastroenterology. 99(6). 1122–1128. 95 indexed citations
15.
Mantzaris, Gerassimos J., et al.. (2003). Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease. Clinical Gastroenterology and Hepatology. 1(2). 122–128. 28 indexed citations
16.
Mantzaris, Gerassimos J., et al.. (2002). Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology. 14(11). 1237–1243. 57 indexed citations
18.
Petraki, Kalliopi, et al.. (2000). Immunohistochemical expression of cytokeratins 7 and 20 in gastric intestinal metaplasia and in Barrett's esophagus. Gastroenterology. 118(4). A226–A226. 4 indexed citations
19.
Mantzaris, Gerassimos J., et al.. (2000). H. pylori infection in common variable immunodeficiency disease (CVID). Gastroenterology. 118(4). A1270–A1270. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026